When exploring the clinical application of CDK1 as a biomarker for liver fibrosis, we must first recognize its central role in cell cycle regulation, which is not only widely recognized in basic biological studies, but also gradually shows its importance in clinical pathology [26]. The gene discussed is CDK1; the disease is Hepatic fibrosis.